Bionexus Gene Lab vs YD Bio
Bionexus Gene Lab is the larger business, with $7.4m of revenue in fiscal 2025 against $596,817 for YD Bio (12.4 times as much). YD Bio grew faster (16.9% against -21.9%). Bionexus Gene Lab kept more of each dollar of sales as profit: a net margin of -40.2% against -1392.6%.
| Latest fiscal year | Bionexus Gene LabBGLC, 2025 | YD BioYDES, 2025 |
|---|---|---|
| Revenue | $7.4m | $596,817 |
| Revenue growth | -21.9% | 16.9% |
| Net income | −$3.0m | −$8.3m |
| Operating margin | — | -883.3% |
| Net margin | -40.2% | -1392.6% |
| Return on equity | -35.2% | — |
| Free cash flow | −$1.9m | −$8.0m |
| Cash | $2.4m | $6.0m |
| Total debt | $0 | $6,764 |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $2.3m | $446m |
| Price vs our value range | — | — |
| Moat score | 23 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 3 buys, 0 sales |